Harold J Petrimoulx

Title: Harold J. Petrimoulx: Innovator in Pharmaceutical Distribution Technologies

Introduction

Harold J. Petrimoulx is a notable inventor based in Phoenixville, PA, with a focus on innovations in the pharmaceutical distribution sector. He holds three patents that showcase his expertise in developing computer-implemented methods and systems aimed at improving the efficiency and effectiveness of controlled substance distribution.

Latest Patents

One of his latest patents is titled "Rating and Ranking Controlled Substance Distribution Stakeholders." This invention describes methods, software, and systems for evaluating stakeholders involved in the distribution of controlled substances. The process includes receiving various data types, such as retail prescription data and encrypted patient data, to aggregate information about pharmaceutical sales at retail outlets. The system then rates these outlets based on the aggregated data.

Another significant patent is the "System for Estimating Product Distribution." This invention estimates sales activity for products at both sampled and unsampled sales outlets by analyzing the distances between them. By correlating sales data from sampled outlets, the system provides a comprehensive estimate of sales activity across all outlets, enhancing the understanding of product distribution.

Career Highlights

Throughout his career, Harold has worked with several companies, including Ims America, Ltd. and Duns Licensing Associates, L.P. His experience in these organizations has contributed to his innovative approach to solving complex problems in the pharmaceutical industry.

Collaborations

Harold has collaborated with notable professionals in his field, including Mark Andrew Felthauser and Preston L. McHenry. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Harold J. Petrimoulx is a distinguished inventor whose contributions to pharmaceutical distribution technologies have the potential to significantly enhance the efficiency of controlled substance management. His innovative patents reflect a deep understanding of the complexities involved in this critical sector.